Balance Sheet - BRIGHT MINDS BIOSCIENCES INC. (DRUG)
$(Billion, Million)| Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 82.97 | 5.72 | 6.83 | 11.71 | 19.85 | 0.80 | 0.08 |
| Accounts receivable, net | 0.41 | 0.05 | 0.04 | 0.16 | 0.11 | ||
| Inventories | -0.04 | ||||||
| Other current assets | 0.99 | 0.22 | 0.03 | 0.16 | 0.17 | 0.08 | |
| Total current assets | 84.31 | 5.99 | 6.81 | 11.95 | 20.04 | 0.88 | 0.08 |
| Total non-current assets | 0.11 | 0.12 | 0.07 | 0.14 | 0.00 | 0.00 | 0.08 |
| Total assets | 84.42 | 6.10 | 6.88 | 12.09 | 20.04 | 0.88 | 0.16 |
| Total current liabilities | 2.34 | 0.53 | 0.28 | 1.47 | 0.64 | 0.15 | 0.04 |
| Total non-current liabilities | 0.04 | 0.04 | 0.00 | 0.07 | 0.60 | 0.14 | |
| Total liabilities | 2.38 | 0.57 | 0.28 | 1.54 | 0.64 | 0.15 | 0.04 |
| Total stockholders' equity | 82.04 | 5.54 | 6.60 | 10.54 | 19.40 | 0.73 | 0.13 |
| Common shares outstanding | 7 | 4 | 4 | 2 | 2 | 1 | 1 |
Show Quarterly Balance Sheet
Balance Sheet - BRIGHT MINDS BIOSCIENCES INC. (DRUG)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 309.47 | 89.05 | 82.97 | 51.45 | 55.68 | 57.90 | 5.72 | 6.28 | 6.02 | 6.85 | 6.83 | 8.22 | 9.76 | 11.30 | 11.71 | 8.73 | 11.55 | 15.20 | 19.85 | 22.09 | 25.45 | 2.06 | 0.80 | 0.00 | 0.00 | 0.08 |
| Accounts receivable, net | 1.14 | 0.50 | 0.41 | 0.27 | 0.23 | 0.07 | 0.05 | 0.02 | 0.55 | 0.05 | 0.04 | 0.10 | 0.03 | 0.06 | 0.16 | 0.10 | 0.21 | 0.15 | 0.11 | 0.08 | 0.04 | 0.00 | ||||
| Inventories | -0.02 | |||||||||||||||||||||||||
| Other current assets | 1.46 | 1.24 | 0.99 | 0.71 | 0.40 | 0.26 | 0.22 | 0.06 | 0.02 | 0.03 | 0.03 | 0.14 | 0.18 | 0.16 | 0.16 | 0.08 | 0.09 | 0.14 | 0.17 | 0.13 | 0.25 | 0.12 | 0.08 | |||
| Total current assets | 312.07 | 90.79 | 84.31 | 52.37 | 56.31 | 58.22 | 5.99 | 6.27 | 6.50 | 6.84 | 6.81 | 8.38 | 9.88 | 11.43 | 11.95 | 8.82 | 11.76 | 15.41 | 20.04 | 22.21 | 25.74 | 2.18 | 0.88 | 0.08 | ||
| Total non-current assets | 0.07 | 0.09 | 0.11 | 0.13 | 0.15 | 0.18 | 0.12 | 0.01 | 0.03 | 0.05 | 0.07 | 0.08 | 0.10 | 0.12 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 | ||
| Total assets | 312.15 | 90.88 | 84.42 | 52.50 | 56.47 | 58.40 | 6.10 | 6.28 | 6.53 | 6.89 | 6.88 | 8.46 | 9.99 | 11.55 | 12.09 | 8.82 | 11.76 | 15.41 | 20.04 | 22.22 | 25.74 | 2.18 | 0.88 | |||
| Total current liabilities | 3.83 | 1.58 | 2.34 | 0.60 | 0.64 | 0.46 | 0.53 | 0.18 | 0.85 | 0.85 | 0.28 | 0.72 | 1.01 | 0.53 | 1.47 | 0.39 | 1.00 | 0.49 | 0.64 | 0.32 | 0.41 | 0.10 | 0.15 | |||
| Total non-current liabilities | 0.00 | 0.02 | 0.04 | 0.06 | 0.09 | 0.11 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.05 | 0.07 | 0.39 | 0.99 | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Total liabilities | 3.83 | 1.60 | 2.38 | 0.67 | 0.73 | 0.57 | 0.57 | 0.18 | 0.85 | 0.85 | 0.28 | 0.73 | 1.04 | 0.58 | 1.54 | 0.39 | 1.00 | 0.49 | 0.64 | 0.32 | 0.41 | 0.10 | 0.15 | |||
| Total stockholders' equity | 308.32 | 89.28 | 82.04 | 51.83 | 55.74 | 57.83 | 5.54 | 6.10 | 5.69 | 6.03 | 6.60 | 7.73 | 8.95 | 10.97 | 10.54 | 8.43 | 10.76 | 14.92 | 19.40 | 21.89 | 25.33 | 2.09 | 0.73 | 0.05 | ||
| Common shares outstanding | 10 | 8 | 7 | 7 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |